SkinHealth Systems Inc. Class A SKIN 深 滬
已收盤 05-08 16:00:00 美东时间
0.58
-0.330
-36.26%
華盛通- 最 高0.8267
- 今 開0.8251
- 成交量 480.89万股
- 最 低 0.5749
- 昨 收 0.91
- 總市值 7515.88万
- 52周最高 2.69
- 市盈率 靜 --
- 換手率 3.71%
- 52周最低 0.5749
- 委 比 -14.14%
- 總股本 1.30亿
- 歷史最高 30.173
- 量 比 3.80
- 振 幅 27.67%
- 歷史最低 0.5749
- 每 手 1
- 風險率 0.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多电话会总结 ｜ Beauty Health(SKIN)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Beauty Health业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 净销售额为6,490万美元，同比下降6.7%，符合6,300万至6,800万美元的指导区间 - 消耗品收入4,640万美元，同比下降6.1% - 设备系统收入1,850万美元，同比下降8.3% - 设备投放量746台，较去年同期的862台下降 **盈利能力：** - 调整后EBITDA为850万美元，同比增长17%，EBITDA利润率为13.1% - 调整后毛利率为72.2%，略高于去年同期的71.9% - GAAP毛利率为68.5%，低
05-10 12:11
Beauty Health Sees Q2 Sales $72.000M-$77.000M vs $76.764M Est
Beauty Health (NASDAQ:SKIN) sees Q2 sales of $72.000 million-$77.000 million vs $76.764 million analyst estimate.
05-08 04:24
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
Canaccord Genuity Maintains Hold on SkinHealth Systems, Lowers Price Target to $1
Canaccord Genuity analyst Susan Anderson maintains SkinHealth Systems (NASDAQ:SKIN) with a Hold and lowers the price target from $1.5 to $1.
05-02 06:24
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
SkinHealth Systems Inc. announced the appointment of three new independent directors: Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie, effective April 17, 2026. Brent Saunders, Chairman, highlighted their expertise in medtech, aesthetics, and consumer brands. Tripp brings experience in medical device manufacturing and supply chain leadership; Shridharani is a plastic surgeon and aesthetic medicine innovator; Beattie has leadership exp...
04-22 20:05
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
TD Cowen Maintains Hold on Beauty Health, Lowers Price Target to $1.5
TD Cowen analyst Oliver Chen maintains Beauty Health (NASDAQ:SKIN) with a Hold and lowers the price target from $1.65 to $1.5.
03-16 21:46
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Gainers Sow Good (NASDAQ:SOWG) shares rose 44.4% to $0.54 during Friday's regu...
03-14 01:06
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
BeautyHealth Expands Skin Health Ecosystem with Growing Adoption of SkinStylus Nano-Channeling, a Popular Pairing with Hydrafacial Treatments
BeautyHealth expands its skin health ecosystem by integrating Hydrafacial treatments with SkinStylus Nano-Channeling, meeting growing demand for combination protocols that enhance results without downtime. Combining deep exfoliation and serum delivery, the protocol improves skin quality, reduces wrinkles, and boosts luminosity, with 77% of providers and 81% of consumers favoring such treatments. The BeautyHealth Company emphasizes this as a strat...
03-09 12:00
